{"id":"skin-repairing-cream","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Skin Repairing Cream is a dermatological product intended to enhance skin repair processes, likely through moisturization, barrier restoration, and promotion of natural healing mechanisms. The exact active ingredients and molecular targets are not publicly detailed, but such creams typically work by reducing transepidermal water loss, supporting keratinocyte function, and facilitating wound healing or skin recovery.","oneSentence":"A topical formulation designed to repair and restore skin barrier function and promote tissue healing.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:34:58.779Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Skin repair and restoration (Phase 3 indication not fully specified in public domain)"}]},"trialDetails":[{"nctId":"NCT07442422","phase":"NA","title":"Endocare Repair Efficacy Skincare Products in the Use of Post-laser Treatment","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2023-04-14","conditions":"Laser Treatment","enrollment":24},{"nctId":"NCT07393191","phase":"NA","title":"Evaluation of Hydrating Cream Effect on Subjects With Dry Skin.","status":"COMPLETED","sponsor":"Lacer S.A.","startDate":"2024-12-17","conditions":"Dry Skin, Sensitive Skin, Cracked Skin","enrollment":35},{"nctId":"NCT07311070","phase":"PHASE3","title":"Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue","status":"ENROLLING_BY_INVITATION","sponsor":"Daryoush Hamidi Alamdari, PhD","startDate":"2025-10-21","conditions":"Advanced Basal Cell Carcinoma (BCC), Inoperable Disease, Morpheaform Basal Cell Carcinoma","enrollment":20},{"nctId":"NCT07311057","phase":"PHASE3","title":"Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy","status":"ENROLLING_BY_INVITATION","sponsor":"Daryoush Hamidi Alamdari, PhD","startDate":"2025-12-20","conditions":"SCC - Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma of Skin, Inoperable Disease","enrollment":20},{"nctId":"NCT07127523","phase":"NA","title":"A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Skin on Improving Acne Symptoms and Skin Repair Among Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"GenCanna Acquisition Corp","startDate":"2026-01","conditions":"Acne","enrollment":150},{"nctId":"NCT02777775","phase":"","title":"Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.","status":"COMPLETED","sponsor":"Corewell Health West","startDate":"2016-05","conditions":"Cutaneous Neurofibromas, Neurofibromatosis Type 1, Plexiform Neurofibromas","enrollment":71},{"nctId":"NCT05339490","phase":"PHASE1, PHASE2","title":"Use of Progenitor Biological Bandages in Burn Care (Bru_PBB)","status":"TERMINATED","sponsor":"Dr Anthony De Buys Roessingh","startDate":"2025-07-01","conditions":"Burn Injury","enrollment":76},{"nctId":"NCT07066280","phase":"PHASE3","title":"Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-04-10","conditions":"Skin Microbiome, Breast Cancer, Radiation Dermatitis","enrollment":326},{"nctId":"NCT06925035","phase":"NA","title":"Efficacy of Combined 1927nm Thulium Fiber Laser and Supramolecular Salicylic Acid in Photoaging Treatment","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2023-06-01","conditions":"Photo-aged Skin, Laser","enrollment":36},{"nctId":"NCT06489418","phase":"NA","title":"A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry and Sensitive Skin.","status":"COMPLETED","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2024-07-30","conditions":"Dry Skin, Sensitive Skin","enrollment":27},{"nctId":"NCT05293717","phase":"PHASE1, PHASE2","title":"Topical Ruxolitinib in Chronic Hand Dermatitis","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2022-07-11","conditions":"Chronic Hand Dermatitis","enrollment":16},{"nctId":"NCT05130814","phase":"NA","title":"EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers","status":"COMPLETED","sponsor":"Emoled","startDate":"2021-12-01","conditions":"Pressure Sore, Pressure Ulcer, Pressure Ulcers Stage III","enrollment":48},{"nctId":"NCT06638905","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin","status":"NOT_YET_RECRUITING","sponsor":"Goldman, Butterwick, Fitzpatrick and Groff","startDate":"2024-10-28","conditions":"Facial Wrinkles, Skin Aging","enrollment":18},{"nctId":"NCT05446402","phase":"PHASE4","title":"Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2022-06-15","conditions":"Acne","enrollment":29},{"nctId":"NCT06271135","phase":"NA","title":"Assessing the Quality of Life of Patients With Rosacea","status":"COMPLETED","sponsor":"Medical University of Bialystok","startDate":"2017-05-08","conditions":"Rosacea","enrollment":160},{"nctId":"NCT05810194","phase":"","title":"Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis","status":"COMPLETED","sponsor":"Stratpharma AG","startDate":"2023-05-01","conditions":"Radiation Dermatitis","enrollment":344},{"nctId":"NCT05641246","phase":"PHASE2","title":"Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine","status":"COMPLETED","sponsor":"German University in Cairo","startDate":"2022-12-08","conditions":"Hand and Foot Syndrome","enrollment":86},{"nctId":"NCT05946005","phase":"PHASE4","title":"Lidocaine, Povidone Iodine, and Honey Application on Second-degree Perineal Tear Healing","status":"COMPLETED","sponsor":"Hasanuddin University","startDate":"2021-12-01","conditions":"Perineal Tear","enrollment":200},{"nctId":"NCT05245383","phase":"NA","title":"Skin Irritation Test of Ten Products","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2021-12-17","conditions":"Dermatitic Reaction of Face","enrollment":30},{"nctId":"NCT04615962","phase":"PHASE1","title":"Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.","status":"UNKNOWN","sponsor":"Seanergy Dermatology Ltd.","startDate":"2021-01-01","conditions":"Atopic Dermatitis","enrollment":66},{"nctId":"NCT03791710","phase":"PHASE3","title":"Effect of Autologous Fat Grafting on Acute Burn Wound Healing","status":"COMPLETED","sponsor":"Ahmed Mohamed Abouzaid","startDate":"2019-03-14","conditions":"Burns","enrollment":100},{"nctId":"NCT03716050","phase":"PHASE2, PHASE3","title":"The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-01-30","conditions":"Perfusion; Complications","enrollment":17},{"nctId":"NCT04202289","phase":"PHASE3","title":"Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study","status":"COMPLETED","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2017-04-03","conditions":"Burns","enrollment":115},{"nctId":"NCT01291940","phase":"NA","title":"The Effects of Emollient Therapy on the Skin Barrier","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2011-01","conditions":"Atopic Dermatitis, Eczema","enrollment":25},{"nctId":"NCT03279328","phase":"PHASE4","title":"Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2017-10-10","conditions":"Actinic Keratoses","enrollment":30},{"nctId":"NCT02765763","phase":"PHASE4","title":"Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules","status":"COMPLETED","sponsor":"Advanced Dermatology","startDate":"2016-05","conditions":"Skin Aging, Photoaging of Skin","enrollment":45},{"nctId":"NCT03264586","phase":"PHASE4","title":"The Effect of Lidocaine - Prilocaine Cream (EMLA) Versus Mepivacaine Infiltration on Pain Relief During And After Mediolateral Episiotomies","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2017-08","conditions":"Episiotomy Pain","enrollment":200},{"nctId":"NCT02153762","phase":"NA","title":"Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2013-04","conditions":"Atopic Dermatitis","enrollment":41},{"nctId":"NCT02695706","phase":"EARLY_PHASE1","title":"Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use","status":"UNKNOWN","sponsor":"LM Farma Indústria e Comércio Ltda.","startDate":"2016-04","conditions":"Diabetes","enrollment":35},{"nctId":"NCT02497326","phase":"NA","title":"Heparin for the Treatment of Burn Wound Pain","status":"UNKNOWN","sponsor":"King Edward Medical University","startDate":"2015-04","conditions":"Second Degree Burns","enrollment":36},{"nctId":"NCT00616538","phase":"PHASE4","title":"Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis","status":"COMPLETED","sponsor":"Ceragenix Pharmaceuticals","startDate":"2006-12","conditions":"Atopic Dermatitis","enrollment":121},{"nctId":"NCT00460083","phase":"PHASE4","title":"Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Ceragenix Pharmaceuticals","startDate":"2007-04","conditions":"Atopic Dermatitis","enrollment":35},{"nctId":"NCT00565552","phase":"NA","title":"Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage","status":"UNKNOWN","sponsor":"University Hospital Schleswig-Holstein","startDate":"2007-01","conditions":"Cicatrix, Hypertrophic, Keloid","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Skin Repairing Cream","genericName":"Skin Repairing Cream","companyName":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","companyId":"sun-yat-sen-memorial-hospital-of-sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A topical formulation designed to repair and restore skin barrier function and promote tissue healing. Used for Skin repair and restoration (Phase 3 indication not fully specified in public domain).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}